The molecular mechanisms behind these findings might be related to the relationship of membranous E-Cadherin loss with progression of EMT, which was found to be associated with reduced responsiveness to fgSRL in somatotropinomas [38]. This evidence concerns the gene CDH1 and growth hormone-producing pituitary gland neoplasm.